ArticleHeliyon2024

iTRAQ-based quantitative proteomics revealing the therapeutic mechanism of a medicinal and edible formula YH0618 in reducing doxorubicin-induced alopecia by targeting keratins and TGF-β/Smad3 pathway.

Renkai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.